非希斯 lysine 乳糖化:瘤生物学中的新兴作用和治疗影响
Qu Zhang1, Bo Luo1, Xinchen Sun2
1Breast cancer center, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, National key clinical specialty construction discipline, Hubei Provincial Clinical Research Center for Breast Cancer, Wuhan Clinical Research Center for Breast Cancer, Wuhan 430079, China.
Ageing research reviews
|August 18, 2025
概括
氨酸乳酸化 (Kla) 是一种翻译后的修改,影响基因转录和蛋白质功能. 这次审查强调了非歇斯顿的Kla.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
背景情况:
- 乳酸盐是糖解的副产物,它诱导了氨酸乳化 (Kla),这是一个翻译后的修饰.
- 克拉调节了重要的生物过程,如转录,新陈代谢,细胞增殖和炎症.
- 克拉最初被发现在组质子上,Kla也修改非组质子蛋白,影响各种细胞功能.
研究的目的:
- 审查最近在非希斯溶乳酸化 (Kla) 研究方面的进展.
- 突出调控因素和非歇斯顿Kla在瘤生物学和治疗耐药性的作用.
- 探索非歇斯顿Kla在癌症诊断,预后和向治疗中的潜在临床影响.
主要方法:
- 关于非希斯溶乳化 (Kla) 的最近研究的文献综述.
- 分析监管机制和非海斯顿基的功能影响 Kla.
- 综合当前对Kla在瘤发生和衰老中的作用的理解.
主要成果:
- 非基因组蛋白Kla直接影响蛋白质的稳定性,活性和局部化,与基因组蛋白Kla对基因转录的影响不同.
- 广泛的非海斯基 Kla 修改涉及瘤发生过程,在衰老过程中经常失调.
- 非海斯Kla在瘤生物学中起着重要作用,包括治疗耐药性.
结论:
- 非歇斯顿Kla是瘤生物学中的关键调节剂,对蛋白质功能有直接影响.
- 对非歇斯顿基因Kla的进一步研究可能会为癌症提供新的诊断和治疗策略.
- 了解非歇斯顿Kla的作用对于推进癌症治疗和了解与衰老相关的疾病至关重要.
相关概念视频
lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Histone Modification
13.8K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.8K
Covalently Linked Protein Regulators
7.1K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.1K
Loss of Tumor Suppressor Gene Functions
5.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


